Cristina Mayor Ruiz

Title: Cristina Mayor Ruiz: Innovator in Ubiquitin Ligase Compounds

Introduction

Cristina Mayor Ruiz is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that stimulate ubiquitination of target proteins. Her work has implications for treating various diseases, including cancer and neurological disorders.

Latest Patents

Cristina holds a patent for "Oxazole and thioazole-type cullin ring ubiquitin ligase compounds and uses thereof." This invention relates to compounds that can induce the ubiquitination of target proteins, which may lead to their degradation through the cullin-RING ubiquitin ligase (CRL) pathway. The compounds are particularly relevant for proteins involved in diseases such as cancer, metabolic disorders, infectious diseases, and neurological disorders. The patent also outlines methods for identifying and testing these compounds, as well as their potential use as medicaments in treating various diseases.

Career Highlights

Cristina is currently associated with Proxygen GmbH, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the field of medicinal chemistry, focusing on the therapeutic potential of ubiquitin ligase compounds.

Collaborations

Cristina collaborates with notable colleagues, including Georg Winter and Stefan Kubicek. These partnerships enhance her research capabilities and contribute to the advancement of her innovative projects.

Conclusion

Cristina Mayor Ruiz is a trailblazer in the development of ubiquitin ligase compounds, with a focus on addressing critical health challenges. Her contributions to science and medicine are paving the way for new therapeutic strategies.